NEW YORK (GenomeWeb News) - Clinical Data’s board of directors yesterday approved a 3-for-2 stock split that will give company stockholders one new share of common stock for every two shares they own.
 
The news drove the company's share price up nearly 13 percent to close at $34.38 yesterday. In late morning trading today, the company's shares had pulled back slightly to $33.96. 
 
The split will occur Sept. 24, and the dividends will be distributed on Oct. 2, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.